China’s NRDL Update: New Drugs Available for Online Procurement
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) drug procurement platform has released a notice stating that...
Mindray Launches First Wireless Handheld Ultrasound System, TE Air
China-based medical device firm Mindray (SHE: 300760) has announced the market launch of the firm’s...
Harbour BioMed Licenses HBM7008 to Cullinan Oncology for US Development
Harbour BioMed (HBM), which operates out of the Netherlands, the United States, and Suzhou, China,...
Kangtai Biological Begins Phase I Trial for Tetravalent Influenza Vaccine
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced the first subject enrollment...
Jiangsu Recbio Completes First Tranche Enrollment for Shingles Vaccine REC610
China-based Jiangsu Recbio Technology Co., Ltd has announced the completion of the first tranche of...
Beijing Wantai Initiates Phase I Study for 20-Valent Pneumonia Vaccine
China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392) has announced the initiation and...
Gracell Biotechnologies Gains IND Approval for GC012F in China
Gracell Biotechnologies has reported receiving Investigational New Drug (IND) approval from the Center for Drug...
China’s Ministries Release Plan for Urban Medical Group Pilots
A group of ministries led by the National Health Commission (NHC), including the National Development...
ThinmedTech Partners with West China Hospital for CKD Digital Therapy
ThinmedTech, a chronic disease clinical management solution provider based in Chongqing, has struck a partnership...
RemeGen Gains NMPA Approval for RC48 and Pyrotinib Clinical Study
China-based RemeGen Ltd (HKG: 9995) has announced receiving the go-ahead from the National Medical Products...
Clover Biopharmaceuticals Administers First Dose of COVID-19 Vaccine SCB-2019 in Zhejiang
China-based Clover Biopharmaceuticals, Ltd (HKG: 2197) has announced the first jab of its COVID-19 vaccine...
Hengrui Pharmaceuticals Licenses SHR2554 to Treeline Biosciences
China’s Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced a licensing agreement with US-based Treeline Biosciences,...
CSPC Pharmaceutical Licenses ADC SYS6002 to Corbus Pharmaceuticals
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced a licensing agreement with Massachusetts-based Corbus...
Mingche Biotechnology Secures Pre-Series A Funding for Medical Device Innovation
China-based high-value medical device firm Mingche Biotechnology (Suzhou) Co., Ltd has reportedly raised “tens of...
Dessight Biomedical Secures Pre-Series A Funding for Ophthalmic Innovations
Hangzhou Dessight Biomedical has reportedly raised “tens of millions” of renminbi in a Pre-Series A...
Luye Pharma Initiates Phase I Study for BA1106, a CD25 Monoclonal Antibody
China-based Luye Pharma Group (HKG: 2186) has announced the first subject dosing in a Phase...
Zelgen’s ZGGS15 Accepted for NMPA Review as First Global BsAb Filing
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that a clinical trial filing for...
Kintor’s GT20029 Shows Positive Results in US Phase I Study for AGA and Acne
China-based Kintor Pharmaceutical Ltd (HKG: 9939) has announced positive topline data from a Phase I...
Hengrui’s HER2-Targeted ADC SHR-A1811 Aims for Breakthrough Designation
China’s Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced that its SHR-A1811, an HER2 targeted antibody-drug...
EOC Pharma’s CDK7 Inhibitor EOC237 Accepted for CDE Review
EOC Pharma, a biotech operating out of the US and China, has announced that a...